logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Michalis V. Karamouzis

laiko general hospital of athens
H指数:46
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced anti-tumor effects of Imatinib and immune checkpoint inhibitors on gastrointestinal stromal tumor cells (GISTs): insights from monoculture and 3D co-culture models

伊马替尼和免疫检查点抑制剂对胃肠道间质瘤细胞（GISTs）增强的抗肿瘤效应：单培养和3D共培养模型的见解

Medical Oncology
IF3.5
2026-07-130
PRE
Panagiotis Sarantis; Christos Vallilas; Ioanna A. Anastasiou; Eleni-Myrto Trifylli; Evangelos Koustas; John Griniatsos; Michalis V. Karamouzis; Athanasios G. Papavassiliou
Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications

肝细胞癌中的调节性T细胞：空间生态位、生物标志物及临床意义

International Journal of Molecular Sciences
IF4.9
2026-05-220
OA
Dimitris Liapopoulos; Panagiotis Sarantis; Georgios Zogas; Eleni-Myrto Trifylli; Thaleia-Eleftheria Bousou; Konstantina Kamitaki; Ioanna A. Anastasiou; Stefania Kokkali; Sotiris Mavromatis; Evangelos Koustas; Ioannis Elefsiniotis; Theodora Biniari; Michalis V. Karamouzis
Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence

探索细胞外囊泡在胰腺癌和肝胆管癌中的作用: 通过人工智能的进展

International Journal of Molecular Sciences
IF4.9
2026-02-040
OA
Eleni Myrto Trifylli; Athanasios Angelakis; Sotirios P. Fortis; Anastasios G. Kriebardis; Nikolaos Papadopoulos; Evangelos Koustas; Panagiotis Sarantis; Michalis V. Karamouzis; Spilios Manolakopoulos; Melanie Deutsch
MicroRNA Landscape in Hepatocellular Carcinoma: Metabolic Re-Wiring, Predictive and Diagnostic Biomarkers, and Emerging Therapeutic Targets

肝细胞癌中的MicroRNA图谱：代谢重编程、预测性和诊断性生物标志物及新兴治疗靶点

Biomedicines 2025, Vol. 13, Page 2243
IF3.9
2025-09-270
OAAI
Dimitris Liapopoulos; Panagiotis Sarantis; Theodora Biniari; Thaleia-Eleftheria Bousou; Eleni-Myrto Trifylli; Ioanna A. Anastasiou; Stefania Kokkali; Dimitra Korakaki; Spyridon Pantzios; Evangelos Koustas; Ioannis Elefsiniotis; Michalis V. Karamouzis
Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial

KRASG12C突变化疗难治性转移性结直肠癌患者接受Sotorasib联合帕尼单抗或标准治疗（CodeBreaK 300）：一项III期随机临床试验的结果

lancet oncology
IF0
2025-08-110
OAAI
Dominik Paul Modest; Marwan Fakih; Lisa Salvatore; Taito Esaki; David Páez Lopez-Bravo; Julien Taieb; Michalis Karamouzis; Erika Ruiz-Garcia; Tae Won Kim; Yasutoshi Kuboki; Fausto Meriggi; David Cunningham; Kun-Huei Yeh; Chiara Cremolini; Qui Tran; Emily Chan; Joseph Chao; Istvan Matyas Majer; Filippo Pietrantonio
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃癌和食管癌：一项随机III期试验的探索性生物标志物分析

NATURE MEDICINE
IF50
2025-03-070
OA
Shitara, Kohei; Janjigian, Yelena Y.; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming
Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Taieb, J.; Fakih, M.; Salvatore, L.; Esaki, T.; Modest, D. P.; Paez, D.; Karamouzis, M. V.; Ruiz, E.; Kim, T. W.; Kuboki, Y.; Meriggi, F. A.; Cunningham, D.; Yeh, K-H.; Cremolini, C.; Wang, J.; Tran, Q.; Chao, J.; Chen, Z.; Pietrantonio, F.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/ gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Additional analyses from 4year (y) follow-up (FU) of CheckMate 649
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Wyrwicz, L. S.; Shitara, K.; Moehler, M.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo Araneda, C. E.; Yamaguchi, K.; Cleary, J.; Elimova, E.; Bruges Maya, R.; Karamouzis, M. V.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; Tehfe, M.; Feeney, K.; Wang, R.; Zhang, J.; Janjigian, Y. Y.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

Sotorasib联合帕尼单抗治疗KRAS G12C突变的难治性结直肠癌

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-12-07104
PRE
Fakih, Marwan G.; Salvatore, Lisa; Esaki, Taito; Modest, Dominik P.; Lopez-Bravo, David P.; Taieb, Julien; Karamouzis, Michalis V.; Ruiz-Garcia, Erika; Kim, Tae-Won; Kuboki, Yasutoshi; Meriggi, Fausto; Cunningham, David; Yeh, Kun-Huei; Chan, Emily; Chao, Joseph; Saportas, Yaneth; Tran, Qui; Cremolini, Chiara; Pietrantonio, Filippo

研究方向

暂未获取到该数据
A
Athanasios G. Papavassiliou
H 指数:79论文数:751被引数:2.3万
P
Panagiotis Sarantis
H 指数:21论文数:108被引数:1,779
E
Evangelos Koustas
H 指数:22论文数:72被引数:4,699
P
Panagiotis A. Konstantinopoulos
H 指数:65论文数:479被引数:1.9万
D
Dimitriοs Schizas
H 指数:46论文数:559被引数:9,778
E
Eleni-Myrto Trifylli
H 指数:12论文数:34被引数:253
I
Ioanna A. Anastasiou
H 指数:13论文数:63被引数:446
J
Jaffer A. Ajani
H 指数:152论文数:1,740被引数:12.2万
Y
Yelena Y. Janjigian
H 指数:67论文数:721被引数:3.7万
T
Tomasz Skoczylas
H 指数:16论文数:95被引数:4,455